Singapore markets closed
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,009.81 -61.82 (-1.22%) Dow
37,860.84 -600.08 (-1.56%) Nasdaq
15,456.26 -256.49 (-1.63%) Bitcoin USD
63,641.88 -1,200.45 (-1.85%) CMC Crypto 200
1,374.28 -8.30 (-0.60%)
GILD Jun 2024 90.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:33PM EDT. Market open.
| Previous close | 0.0200 |
| Open | 0.0500 |
| Bid | 0.0100 |
| Ask | 0.2000 |
| Strike | 90.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.0200 - 0.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.32k |
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?
Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksGilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
© 2024 Yahoo. All rights reserved.